Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of <i>Pseudomonas aeruginosa</i> From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards-SMART United States 2017-2019.

Open Forum Infect Dis · 2021 · PMC8297703 · PMID 34307727

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Among the nonsusceptible subsets, the differences in antimicrobial susceptibility between isolates from ICUs and non-ICU wards were smaller and often did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.